Research Groups and R&D Platforms: Cancer
Research Group:
Mitosis, microRNAs and drug discovery
Marko Kallio
marko.kallio[at]utu.fi
Department of Physiology,
University of Turku
Assay development, Basic research, Biomarker, Biomedicine, Breast cancer, Cancer, Drug target, High throughput imaging, Imaging, In Vitro Diagnostics, Molecular Cell Biology, Ovarian cancer, Prostate cancer, Signaling, Target discovery
Research Group:
Hormonal cancer growth and metastasis
Pirkko Härkönen
harkonen[at]utu.fi
Institute of Biomedicine,
University of Turku
Ageing-related diseases, Basic research, Biomarker, Breast cancer, Cancer, Disease models, Drug target, Personalized medicine, Prostate cancer, Receptor, Signaling, Target discovery
Research Group:
Intracellular signalling regulated by Pim kinases
Päivi Koskinen
paivi.koskinen[at]utu.fi
Department of Biology,
University of Turku
Intracellular signalling regulated by PIM kinases
Basic research, Biomedicine, Breast cancer, Cancer, Data mining, Disease models, Drug delivery, Drug target, Fluorescence spectroscopy, Imaging, Imaging software, Molecular Cell Biology, Molecular modelling, Nanoparticles, Prostate cancer, Proteomics, Screening, Signaling, Squamous cell carcinoma, Target discovery, X-ray crystallography
Research Group:
Biomarkers for ovarian cancer
Kaisa Huhtinen
kaisa.huhtinen[at]utu.fi
Institute of Biomedicine,
University of Turku
Ageing-related diseases, Biomarker, Biomedicine, Cancer, Diagnostics, Genomics, In Vitro Diagnostics, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Ovarian cancer, Pathology, Personalized medicine
Research Group:
Herpesviruses as friends and enemies
Veijo Hukkanen
veijo.hukkanen[at]utu.fi
Institute of Biomedicine,
University of Turku
Autoimmune diseases, Basic research, Biomedicine, Cancer, Disease models, Imaging, In Vitro Diagnostics, Infection, Inflammation, Next-generation sequencing, Nucleic acids, Virology
Research Group:
Bioactive natural compounds
Patrik Eklund
paeklund[at]abo.fi
Laboratory of Organic Chemistry,
Åbo Akademi University
Cancer, Diabetes, Hit to lead, Inflammation, Lead optimization, Natural Compounds, Natural products, NMR, Organic Chemistry, Organic compounds, Synthetic chemistry
